GERMANY: BYK GULDEN, BAYER GASTROENTEROLOGY DEAL
Article Abstract:
In Germany, Konstanz-based Byk Gulden has acquired from Bayer AG the worldwide exclusive rights to the development and sales of a new active agent for the treatment of gastric and duodenal ulcers. It is believed that the agent called BY 377 might make monotherapy of helicobacter pylori possible. Byk Gulden is to start clinical tests in mid-2000. Bayer will continue to produce the agent.
Publication Name: Europa Chemie
Subject: Chemicals, plastics and rubber industries
ISSN: 0014-2484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
GERMANY: MORE CARBONIC ACID FROM RUHRCHEMIE
Article Abstract:
Ruhrchemie, a unit of Celanese, has raised the production of carbonic acid by 30% to 36,000 tpy at the factory in Oberhausen. The investment amounted to DM 5.5mn.
Publication Name: Europa Chemie
Subject: Chemicals, plastics and rubber industries
ISSN: 0014-2484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic: